Respirogen Email Format

Biotechnology ResearchColorado, United States2-10 Employees

Respirogen is a biotechnology research company based in Boulder, Colorado. The company is developing technology intended to provide oxygen independently of damaged lungs, addressing a critical need in severe lung injury. In particular, it targets ARDS, a condition commonly encountered in intensive care units and triggered by events such as pneumonia or trauma, involving damage to the lung–blood barrier and resulting in protein-rich fluid buildup and rapid respiratory failure with low oxygen levels that often do not respond to standard oxygen therapy and may require ventilation support.

Its potential customers are clinicians and healthcare providers treating ARDS in ICU settings, where oxygenation remains a critical challenge. The description positions the company within the biotechnology research space, pursuing a way to support oxygen delivery when the lungs are severely damaged.

Sign up for free to view info

Company overview Employee directory